Calithera Biosciences (NASDAQ:CALA) reported quarterly losses of $(2.01) per share which missed the analyst consensus estimate of $(1.93) by 4.15 percent. This is a 33 percent increase over losses of $(3.00) per share from the same period last year.
$1000 Invested In NXP Semiconductors 10 Years Ago Would Be Worth This Much Today
NXP Semiconductors (NASDAQ:NXPI) has outperformed the market over the past 10 years by 7.64% on an annualized basis…
